"CD4-positive, alpha-beta T cell differentiation"

pathway activity — cross-omics
GO:0043367Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the "CD4-positive, alpha-beta T cell differentiation" pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are ARHGAP9, DOK3, and WAS, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, "CD4-positive, alpha-beta T cell differentiation" activity versus ARHGAP9 in GBM (Pearson r = 0.32).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMARHGAP9 →+0.876+0.613<.001<.00137
UCECDOK3 →+0.793+0.444<.001<.00137
GBMWAS →+0.820+0.509<.001<.00137
HNSCMEFV →+1.009+0.608<.001.00137
GBMLCP2 →+0.987+0.460<.001<.00137
LSCCCD7 →+0.663+0.634<.001<.00137
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0043367 vs ARHGAP9 — GBM

Per-sample scatter of

Explore this scatter interactively →

Exploration